HOME >> BIOLOGY >> NEWS
Genetic Association Information Network announces genotyping awards for 6 common diseases

BETHESDA, MARYLAND - Tuesday, Oct. 10, 2006 -- The Foundation for the National Institutes of Health (FNIH) today announced that six major studies of common diseases have been selected as the first to undergo whole genome analysis by the Genetic Association Information Network (GAIN).

This type of analysis is designed to identify the genetic contributions to common illnesses that affect the public health, such as depression and diabetes. Using biological samples already collected in earlier clinical studies, GAIN will comprehensively evaluate the subtle differences between the genomes of approximately 1,000-2000 normal, healthy volunteers and the genomes of 1,000-2000 patients with the condition being studied. Identifying genetic differences between the two groups will speed up the development of new methods to prevent, diagnose, treat and even cure common conditions.

The Genetic Association Information Network is a unique public-private partnership involving the National Institutes of Health (NIH), Pfizer, Inc., of New York City, Affymetrix, Inc., of Santa Clara, CA, and the FNIH, as well as Perlegen Sciences, Inc., of Mountain View, CA., Abbott, of Abbott Park, IL, and the Broad Institute of Massachusetts Institute of Technology and Harvard University in Cambridge, MA.. GAIN was established in February, 2006 to help find the genetic causes of common diseases by conducting large-scale genomic studies and making their results broadly available to researchers worldwide. Private donors have contributed approximately $26 million to the project in order to stimulate rapid progress in this field. Companies funding this partnership, however, will not receive any special benefits from GAIN, such as advanced access to the data.

"Public-private partnerships like GAIN bring new scientific and financial resources to the NIH's existing whole genome association programs, accelerating our progress in this important new field of research," said D
'"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
10-Oct-2006


Page: 1 2 3 4

Related biology news :

1. Genetic variation helps to understand predisposition to schizophrenia
2. Genetic factors strongly shape how peers are chosen
3. Genetic analysis finds greater threat in frog-killing fungus
4. Genetic diversity in honeybee colonies boosts productivity
5. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced
6. Maynard Olson receives $500,000 Gruber Genetics Prize
7. Genetic defect links respiratory disease and congenital heart disease
8. Cell Press announces new partnership with the American Society of Human Genetics
9. Genetic fellow traveler discovered in Alzheimers
10. Genetic roots of bipolar disorder revealed by first genome-wide study of illness
11. Health disparities -- Genetics, society and race play an important role in access to healthcare

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... , ... June 04, 2020 , ... Greffex, a pioneering ... its Board of Directors. , “Neil understands the need for a global perspective to ... and CEO of Greffex. Mr. Bush will serve as an independent, director of the ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric ... Group (CEG) to market and sell its complete line of biometric readers and ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales ...
(Date:5/28/2020)... Texas (PRWEB) , ... May 28, 2020 , ... ... announced today that interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT ... (ASCO) Annual Meeting which will take place virtually on May 29th, 2020. Dr. ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license ... to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a leading ... despite many obstacles created as a result of COVID-19. As a provider at ... medical practices and medical manufacturers by expanding access to device offerings, technology services, ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen ... will be presented June 22-24 during the American Association for Cancer Research Virtual ... other profiles the potent, consistent single agent activity in KEAP1 mutant tumor models ...
Breaking Biology Technology:
Cached News: